Drug Education Guide

Avelumab (Patient)

Immunotherapy Monoclonal antibody PD-L1 inhibitor

Avelumab (Patient)

Immunotherapy Monoclonal antibody PD-L1 inhibitor
Light Sensitive Fall Risk
Medication Basics

Drug Name

Avelumab (Brand names: Bavencio®)

Purpose / Indication

Used to treat certain cancers, including Merkel cell carcinoma, urothelial carcinoma, and some cases of renal cell carcinoma when ordered by the oncology team.

Dosage & Administration

Dose Schedule

Often administered as an intravenous infusion every 2 weeks, but the exact dose and schedule depend on diagnosis, body weight, combination therapy, and institutional protocol.

Route

IV (Intravenous)

Timing Considerations

Treatment is given in cycles. The infusion schedule is determined by the oncology team and may change if side effects occur.

Time of Day

Flexible

Special Instructions

Keep all appointments and tell your care team about new symptoms before each treatment.

Injection Techniques

This medicine is given by trained healthcare professionals through an IV line.

Mechanism of Action

Mechanism

This medicine helps your immune system recognize and attack cancer cells by blocking a signal cancer cells may use to hide from immune attack.

13 More Sections — Members Only

Free membership unlocks the complete guide.

  • Side Effects
  • Drug Interactions
  • Contraindications
  • Monitoring
  • Adherence
  • + 8 more…
Was this guide helpful?